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Determining bacterial and host contributions to the human salivary
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ABSTRACT
Background: Salivary metabolomics is rapidly advancing.
Aim and methods: To determine the extent to which salivary metabolites reflects host or
microbial metabolic activity whole-mouth saliva (WMS), parotid saliva (PS) and plasma
collected contemporaneously from healthy volunteers were analysed by 1H-NMR spectro-
scopy. Spectra underwent principal component analysis and k-means cluster analysis and
metabolite quantification. WMS samples were cultured on both sucrose and peptide-enriched
media. Correlation between metabolite concentration and bacterial load was assessed.
Results: WMS contained abundant short-chain fatty acids (SCFAs), which were minimal in PS
and plasma. WMS spectral exhibited greater inter-individual variation than those of PS or
plasma (6.7 and 3.6 fold, respectively), likely reflecting diversity of microbial metabolomes.
WMS bacterial load correlated strongly with SCFA levels. Additional WMS metabolites includ-
ing amines, amino acids and organic acids were positively correlated with bacterial load.
Lactate, urea and citrate appeared to enter WMS via PS and the circulation. Urea correlated
inversely with WMS bacterial load.
Conclusions: Oral microbiota contribute significantly to the WMS metabolome. Several WMS
metabolites (lactate, urea and citrate) are derived from the host circulation. WMS may be
particularly useful to aid diagnosis of conditions reflective of dysbiosis. WMS could also
complement other gastrointestinal fluids in future metabolomic studies.
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Introduction
Saliva is an emerging fluid in diagnostic science, offer-
ing advantages over fluids more widely used for diag-
nostic purposes. Saliva collection is less invasive than
plasma collection, and saliva can be produced ad-
libitum unlike urine [1]. To allow the full diagnostic
potential of saliva to be reached, much research pertain-
ing to salivary biomarker discovery currently empha-
sises optimisation either of sample handling or analytic
techniques [2–6] and assessing physiological modifiers
in health such as diurnal variation, diet and age [7,8].
Recently, metabolic profiling of saliva by proton
Nuclear Magnetic Resonance spectroscopy (1H-NMR)
has revealed discriminatory metabolic signatures for
several diseases. These include oral pathologies such as
dental caries [9,10], periodontal disease [11,12] and
Sjögren’s syndrome [13] as well as extra-oral conditions
such as dementia [14] and type 1 diabetes [15]. Both
caries and periodontal disease are of microbial aetiol-
ogy. It therefore appears that differences in salivary
metabolic composition can reflect dysbiosis of the oral
microbiota. Several studies of salivary metabolic
composition have touched on the role of bacteria in
generating or consuming salivary metabolites [11,16–
18]. Despite identification as a subject requiring further
research [18], the extent of host-derived and bacterial
contributions to salivarymetabolites has not specifically
been studied. While knowledge of the composition of
the oral microbiome has undergone rapid advance-
ments due to advances in sequencing technology, mov-
ing towards studying the collective metabolic activity of
this complex system, represents a crucial step in under-
standing oral health and disease [19].
The majority of 1H-NMR studies of saliva have been
focused on whole-mouth saliva (WMS). WMS is
a complex fluid derived from three major paired salivary
glands and hundreds of minor glands throughout the
oral cavity, containing hundreds of millions of bacteria
per millilitre, as well as millions of host-derived cells [4].
The cellular content of WMS has been identified as
complicating the analysis of whole mouth saliva, as bac-
teria and neutrophils may have ongoing metabolic activ-
ity, thus care is required in preventing artefactual
changes in samples following collection [5].
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This issue can be addressed by aseptic collection of
saliva directly from the gland. This is most commonly
via the parotid gland, where if collected appropriately,
the saliva is sterile [20]. This secretion therefore does
not enter the oral cavity and is prevented from mod-
ification by oral bacteria, reflecting only host meta-
bolic activity. Relatively, few studies have conducted
metabolic analysis of parotid saliva (PS) by 1H-NMR.
However, one of the earliest NMR investigations of
saliva was conducted on PS, as well as saliva isolated
from the submandibular/sublingual glands. Despite
challenges of low field strength and signal to noise
ratio, several assignments were made although the
aromatic portion of the spectra was not reported
[21]. More recently, PS was analysed alongside
WMS collected from the same individual, with sev-
eral differences in the metabolic profile being
detected, although the sample size of only one pre-
cluded statistical analysis [22].
Analysis of different fluids (typically plasma and
urine samples) has been conducted in various studies
[23–26], however, inclusion of saliva is rare. One
large scale 1H-NMR metabolomic study has included
saliva alongside plasma and urine, albeit collected at
different times, however, the intention was not to
draw comparison between the different fluids but
simply assess them independently [27].
The aim of the present study was to investigate the
extent to which metabolites present in WMS are
derived from the oral microbiota or the host by
comparison of WMS, PS and plasma collected
contemporaneously.
Materials and methods
Sample collection
Samples were collected following ethical approval from
King’s College London ethics committee (HR-15/
15–2508) and with the informed consent of participants.
A total of 11 healthy (self-reported absence of disease/ill-
health), non-smoking volunteers aged 22–31 years with
no obvious oral pathology or antibiotic use over the
preceding 3 months participated. Participants self-
reported oral health status was confirmed by a visual
inspection from a qualified dentist, determined by lack
of caries, plaque deposition, or gingival inflammation.
Radiographic examination was not conducted. Samples
were collected during afternoons at least 1 h after oral
exposure to exogenous substances (eating, chewing gum,
smoking or oral hygiene) or exercise following our pre-
vious protocol [4].
Unstimulated WMS was collected by expectoration
into sterilised universal tubes, over a period of 5 min.
Simultaneously, blood was collected into heparinised
capillaries by lancing the finger with a sterile lancet
following disinfection with isopropanol. PS was
subsequently collected by placing a sterilised Lashley
cup over the opening of the parotid duct. The Lashley
cup was left in place in the absence of stimulation for
10 min, and unstimulated PS was collected. The cup
was then flushed with air, replaced and stimulated PS
was collected. Citrate had previously been identified
as an endogenous metabolite in PS. To avoid the
potential for contamination, 1 ml of 2% food grade
tartaric (rather than citric) acid was placed onto the
tongue in approximately 0.25 ml increments at 30 s
intervals as a stimulus.
Sample preparation and storage
All fluids were maintained chilled during processing.
Saliva samples were centrifuged at 15,000 g for 10
min at 4°C. The supernatant was collected, and the
cell pellet was discarded. Although acellular, PS was
subject to the same centrifugation as WMS for pur-
poses of standardisation. Blood capillaries were sealed
with capillary clay and centrifuged (1,600 g for
15 min at 4°C) to yield plasma as described by
Dona et al. [28]. The remaining cell portion was
discarded. Samples were centrifuged within minutes
of collection, with the exception of a WMS aliquot
taken for bacterial culture. Processed samples were
then immediately transferred to freezer storage at
−80°C prior to analysis.
Bacterial culture of WMS
Two types of media were prepared. Tryptone, yeast
extract and cysteine (TYC) media enriched with
sucrose and designed to select for saccharolytic spe-
cies made to the specification of Wade et al. [29].
The second medium was fastidious anaerobe agar
(FAA) with 5% defibrinated horse blood, intended
to select for bacteria that catabolise peptides and
amino-acids. Prior to centrifugation for NMR (see
below), an aliquot of WMS was taken and serially
diluted tenfold in sterile phosphate-buffered saline
(PBS). Plates of both media types were inoculated
with 25 µl of WMS dilution (1:100 for the sucrose
media and 1:10,000 for the FAA with horse blood).
Plates were grown in an anaerobic cabinet for 48 h,
and the colony-forming units per millilitre (CFU/ml)
of WMS grown on both media types were estimated.
1H-NMR spectroscopy
Sample preparation, spectral acquisition, and spectral
processing are described in detail elsewhere [4].
Samples were analysed in a 600 MHz spectrometer
(Bruker, Karlsruhe, Germany) at a proton frequency
of 600.2 MHz at 25°C using a CPMG spin-echo pulse
sequence with presaturation to edit out macromole-
cule resonances from the spectra. The total echo time
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was 64 min with a relaxation delay of 4 s, and acqui-
sition time of 2.32 s. In total, 256 transients were
collected following four dummy scans, with 64 k
data points and spectral width of 20 ppm (−5 to 15
ppm). Samples were analysed after a single freeze
thaw cycle and maintained at 4°C prior to analysis.
WMS and stimulated PS were prepared unmodi-
fied in a 5 mm OD NMR tube (500 µl sample) with
a coaxial 3 mm OD NMR tube containing 300 µl
1 mM trimethylsilyl-[2,2,3,3,-2H4]-propionate (TSP)
standard with 50% deuterium oxide. Due to plasma
collection by finger prick and the naturally low flow
rate of unstimulated PS and plasma, the lower sample
volumes of these fluids required different prepara-
tion. Unstimulated PS was analysed by putting the
sample in the 3 mm OD NMR tube and the standard
in the 5 mm OD tube. In most cases, plasma samples
were limited to 100 µl, therefore samples were pre-
pared in a 1:2 plasma: buffer ratio as described by
Beckonert et al. [30] and analysed in a 3 mm NMR
tube. The same protocol recommends formate as an
internal standard as opposed to TSP, however, endo-
genous formate was observed in preliminary plasma
samples. Pyrazine was therefore chosen as an internal
standard at a concentration of 0.33 mM [31,32]. The
pH was adjusted to 7.4. A spectrum of the tartaric
acid stimulus was also acquired to ensure there was
no contamination of stimulated PS.
Urea validation
Urea was observed in the biofluid 1H-NMR spectra,
however, due to proton exchange between urea and
water, absolute quantification of urea by 1H-NMR
was not possible from the acquired spectra [33].
Thus, urea was also measured by a colorimetric
assay (Invitrogen). Samples were diluted in water
1:5 for saliva and 1:10 for plasma.
Statistical analysis
Sample size was estimated a priori based on prelimin-
ary analysis of previously collected samples and ade-
quate power confirmed for the relevant statistical
analyses using G*Power (Universität Düsseldorf,
Germany). Data are shown in supplemental Table 2.
In addition to manual integration of metabolite peaks
as previously described [4], processed spectra were
integrated in 0.04 ppm buckets from 0.72 to 8.48 ppm
(MestRec v, MestreLab Research). Residual isopropa-
nol signals from the disinfectant swab were detected
in some plasma samples, thus buckets corresponding
to these regions were excluded from all spectra, as
was the water peak (4.5–5.5 ppm). Each bucket inte-
gral was normalised to the total spectrum integral
thereby removing effects from inter-individual differ-
ences in metabolite concentrations.
Principal components analysis (PCA) and k-means
cluster analysis were performed on bucketed spectral
integrals of all samples in the KNIME analytics plat-
form (Konstanz, Germany). PCA was also conducted
to reveal the most discriminatory bucket of spectral
regions between WMS and PS. To quantify the spec-
tral variability of the different fluids, the mean
Euclidean distance between all samples for each bio-
fluid type was calculated. The first three dimensions
of the projected PCA coordinates for each sample
were multiplied by the relevant principal component-
weighting factor. Euclidean distance between all
weighted projected samples of each biofluid type
was measured in a pairwise manner (i.e. 55 total
measurements for 11 samples) and averaged.
Key metabolite peaks were quantified, inspected
for normality and differences were analysed by paired
t-test or repeated measures ANOVA with Bonferroni
post-hoc where appropriate in SPSS. Metabolite con-
centrations in WMS were correlated with bacterial
load (CFU/ml).
Results
Participant and sample details
Samples were collected from 11 participants (5
males, 6 females) aged 22–31, mean age was
25.5 years. All participants had a healthy unstimu-
lated WMS flow rate (> 0.4 g/min). Three partici-
pants failed to produce PS in the absence of
stimulation. Stimulated PS was successfully col-
lected from all participants.
Biofluid spectral profile
PCA and K-means cluster analysis of the different
biofluid spectra are shown in Figure 1. Spectral pro-
files of plasma and PS (both stimulated and unstimu-
lated) were observed to individually cluster tightly,
whereas WMS spectral profiles were more dispersed
and spread over two statistical clusters. There was no
overlap of different fluids within any cluster, indicat-
ing distinct metabolomic profiles of the different
fluids. Unstimulated parotid plasma samples dis-
played the lowest mean Euclidean distance (i.e. tight-
est clustering) of the different biofluids. Stimulated
PS samples showed slightly wider clustering than
unstimulated PS (1.19-fold greater mean Euclidean
distance). Relative to unstimulated PS, the mean
Euclidean distances between samples for plasma and
whole-mouth saliva were 1.87 and 6.74, respectively.
The metabolite profile of whole mouth saliva there-
fore displayed the greatest inter-individual variation
of the fluids.
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Individual metabolite concentrations
A comparison of the spectral profiles of WMS and
stimulated PS with key metabolites identified is illu-
strated in Figure 2. Comparisons are made between
WMS and stimulated PS as opposed to unstimulated
PS as unstimulated PS is impractical to collect in
a clinical setting, with three of our participants failing
to produce any of the fluid. No trace of the tartaric
acid stimulus (supplemental Figure 1) was identified
in stimulated parotid samples, indicating no contam-
ination between sample and stimulus. Figure 1 indi-
cates that stimulation does not affect the overall
normalised spectral profile of PS. Individual metabo-
lite concentration of stimulated and unstimulated PS
tended not to be significantly different, with the
exception of urea, which was higher in unstimulated
PS (supplemental Table 1).
The difference spectrum (Figure 2(c)) is a digital
subtraction of the PS spectra from the WMS spectra.
The spectral profile is similar to that of WMS but
with fewer broad peaks and a smoother baseline,
likely due to similarities in the macromolecule profile
of WMS and PS. Notably lactate and citrate are barely
visible in the difference spectra as they are at similar
concentrations in both fluids. Alongside urea, the
unassigned PS peaks visible at 2.12 to 2.14 ppm in
PS (marked ‘*’) are some of the only peaks to be
projected negatively, i.e. more concentrated in PS
than WMS.
PCA of WMS and PS spectral regions revealed that
the most discriminatory buckets were between 1.88 and
1.96 ppm, likely reflecting the presence of acetate. In
WMS, acetate was consistently the most abundant meta-
bolite present but close to the limit of quantification in
PS. Other short-chain fatty acids (SCFAs) were similarly
abundant in WMS but absent from or sub-quantifiable
in PS and plasma including butyrate and propionate.
Formate was present in all fluids but was statistically
lower in PS than WMS. Concentrations of SCFAs in
the biofluids are presented in Figure 3(a).
Other metabolites observed in all fluids included
lactate, urea and citrate, Figure 3(b). Lactate levels
were significantly higher in plasma than WMS or PS
whereas citrate levels were generally higher in PS than
plasma although statistical difference was not reached.
Urea was also higher in plasma than WMS or PS, with
urea generally higher in the PS than WMS.
Relationship between metabolite concentration
and bacterial load
Salivary bacterial load ranged from 500 to 250,000
CFU/ml for saccharolytic bacteria and 9.5 × 106 and
7.8 × 108 CFU/ml for proteolytic bacteria. The relation-
ship between bacterial load and metabolite concentra-
tion is presented in Table 1. A number of strong
correlations betweenmetabolite concentration and bac-
terial load were observed, particularly bacterial load of
proteolytic bacteria. Notably, these were for the SCFAs,
acetate and propionate (the first and secondmost abun-
dant salivary metabolite, respectively); the amino acids,
phenylalanine and glycine; and the organic acids, suc-
cinate and pyruvate. Urea was the only metabolite to
inversely correlate with bacterial load.
Figure 1. a – PCA plot of all samples, with fluid type indicated by shape. b – K-means cluster analysis of samples with shapes
indicating separate statistical clusters. Samples clustered based on fluid type with WMS samples spreading over two clusters and
PS and plasma samples forming tighter distinct clusters. Both stimulated and unstimulated PS samples were clustered together.
There was no significant biological difference between the WMS samples in clusters 2 and 3.
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Relationship between salivary urea measured
colorimetrically and by 1H-NMR
Strong correlations were observed between relative urea
concentrations measured by colorimetric assay and by
1H-NMR for both WMS and PS (R2 = 0.85; p < 10−4),
Figure 4. However, absolute concentrations measured
by 1H-NMR were typically five times lower than those
measured by colorimetric assay, likely reflecting proton
exchange with water and suppression resulting from
presaturation of the nearby water signal. For this rea-
son, where absolute concentrations of urea are required
rather than relative concentrations, then measurement
of urea in biofluids by 1H-NMR alone is not ideal.
Discussion
The metabolic composition of WMS measured by
1H-NMR is dominated by SCFAs, in particular acetate,
propionate, butyrate, and to a lesser extent, formate.
Interactions between gut microbiota (and by extension
its metabolome) and host health is a rapidly growing
research area [34], with the concept of the metabolome
providing a ‘functional readout’ of the microbiome being
demonstrated [35]. Acetate, propionate and butyrate are
recognised as products of bacterial fermentation in the
gut, where they are increasingly understood to have
multiple important roles in health [36,37]. While acetate
produced in the gut reaches sufficiently high concentra-
tions to enter the systemic circulation, acetate concentra-
tions in glandular PS were several orders of magnitude
lower than corresponding levels in WMS. Similarly, the
absence of propionate and butyrate in PS compared with
relatively high levels in WMS, as well as the strong
correlations with salivary bacterial load indicates these
metabolites are generated in the mouth by oral bacteria.
Such a relationship was also found for some lower con-
centration salivary metabolites such as methylamine,
dimethylamine and trimethylamine. Signalling via tri-
methylamine/trimethylamine oxide represents an
Figure 2. Partial 1D 600 MHz 1H-NMR spectra of WMS (a), stimulated PS (b) and the subsequent difference spectrum (WMS
minus PS), (c). The aromatic region (8.5–5.5 ppm) is at an increased (x 8) vertical scale relative to the aliphatic region (4.5–0.7
ppm). Peaks marked ‘*’ are unassigned. Acetate has been truncated in the WMS and difference spectra.
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additional communication pathway between host and
microbiota [38]. Given the growing interest in gutmicro-
biota, this work raises the question as to whether there is
a link between salivarymetabolite profiles andmetabolite
profile of other gastrointestinal fluids. This has not been
directly studied, however, evidence suggests both oral
and gut microbiomes relate to cardiovascular health
and plasma lipid metabolism [39]. Similarly, whether
salivary metabolites have a role in maintaining the
epithelial integrity of the oral mucosa analogous to gut
metabolites such as butyrate for colonic epithelium
remains to be investigated. WMS may present an easily
acquired fluid to complement other gastrointestinal
fluids in future studies.
Host-derived metabolites appearing to enter WMS
from the circulation via the salivary glands are also
important constituents of saliva. This study showed
no difference between lactate concentration in PS and
WMS although salivary lactate had been suggested to
be of microbial origin in WMS [18]. Previous work has
Figure 3. a – Concentrations of short chain fatty acids in WMS, stimulated PS and plasma. For purposes of scale, the y-axis is
interrupted for acetate. b – Concentrations of lactate, citrate and urea in WMS, PS and plasma. Urea measurements are from
colorimetric assay. All p-values reflect a Bonferroni post-hoc test after repeated measures ANOVA, n = 11.
Table 1. Summary of whole mouth saliva metabolite concentration and their correlation with salivary bacterial load.
(* = p < 0.05; ** = p < 0.01), n = 11. Urea measurements are from colorimetric assay.
Molecule class Metabolite
Concentration (mmol/L)
Mean (Range)
Correlation with sucrose
enriched media (saccharolytic
bacterial load) (Pearson’s r; p value)
Correlation with horse blood/peptone
enriched media (proteolytic
bacterial load) (Pearson’s r; p value)
Short chain fatty acids Acetate 5.03 (1.53–12.26) 0.72*; 0.01 0.85**; 0.001
Butyrate 0.29 (0.12–1.00) 0.72*; 0.01 0.70*; 0.02
Propionate 0.90 (0.12–2.60) 0.67*; 0.02 0.83**; 0.002
Formate 0.07 (0.006–0.13) NS NS
Amines Dimethylamine 0.01 (0.003–0.015) 0.63*; 0.04 0.64*; 0.04
Methylamine 0.012 (0.008–0.021) NS 0.71*; 0.01
Trimethylamine 0.007 (0.002–0.015) 0.74**; 0.009 0.67*; 0.02
Amino acids Phenylalanine 0.06 (0.02–0.16) 0.74**; 0.009 0.80**; 0.003
Glycine 0.26 (0.06–1.07) 0.78**; 0.004 0.82**; 0.002
Tyrosine 0.10 (0.04–0.18) NS NS
Histidine 0.06 (0.02–0.08) NS NS
Alanine 0.08 (0.013–0.12) NS NS
Organic acids Citrate 0.05 (0.02–0.10) NS NS
Lactate 0.13 (0.05–0.27) NS NS
Pyruvate 0.19 (0.10–0.39) NS 0.83**; 0.001
Succinate 0.24 (0.10–0.61) NS 0.81**; 0.003
Other Choline 0.03 (0.10–0.06) NS 0.72*; 0.012
Methanol 0.05 (0.02–0.10) NS NS
Acetoin 0.04 (0.02–0.08) NS NS
Taurine 0.19 (0.05–0.25) NS NS
Amides Urea 0.83 (0.11–1.41) − 0.81**; 0.003 − 0.63*; 0.04
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shown that within seconds of exposure to exogenous
sucrose, WMS lactate concentrations experience
a rapid increase, as do levels of pyruvate and succinate
[4]. The fasted state (1 h) of the participants in this
study indicates that in the absence of recent nutrition,
salivary lactate is not a significant metabolite of the
healthy oral microbiota. The relatively low lactate levels
observed in WMS likely reflect a baseline lactate enter-
ing PS from circulating plasma. This may explain the
lack of correlation observed between lactate (the pri-
mary product of saccharolytic oral bacteria such as
Streptococcus mutans) and the saccharolytic bacterial
load. Modifiers of plasma lactate, including exercise,
would therefore require consideration when measuring
salivary lactate for diagnostic purposes. Differential
metabolic activity based on nutrient availability could
present a key difference between the metabolome of the
oral cavity and the gut, the latter receiving a more
constant nutrient presence than the mouth.
The reduction of urea in WMS relative to PS and the
inverse correlation with the saccharolytic bacterial load
indicates utilisation of host-derived metabolites by the
oral microbiota. Urea is implicated in elevating oral pH
via conversion to ammonia, thus microbial urea con-
sumption could be a survival mechanism in the presence
of increased growth of acidogenic saccharolytic bacteria
[40]. In the case of citrate, salivary levels were on average
elevated above plasma levels indicating the possibility of
either citrate production by salivary glands or active
transport from plasma. While it is well-recognised that
fluids such as prostatic fluid contain high levels of actively
concentrated citrate [41], the role of salivary citrate is
unclear. Given the fact that citrate concentrations are
maintained to a greater degree than the total protein
concentration (supplemental Table 1) during stimulation
of PS secretion, whereby the fluid output increases at least
ten-fold [42], this suggests an active transportmechanism
of citrate into PS.
This study suggests that the metabolic composition
of saliva is more reflective of the microbiota than the
underlying host metabolism. As evidenced by PCA of
1H-NMR spectra of WMS, PS and plasma, the basic
metabolic fingerprint of WMS displays much greater
inter-individual variation than that of PS and plasma.
This likely reflects the diversity of the oral microbiota
modulating WMS metabolites, whereas PS and plasma
are largely influenced by host physiology and therefore
more closely regulated. Compared to WMS, literature
on PS as a diagnostic fluid is lacking, however increased
study of this fluid either alone or alongside whole
mouth saliva could open new avenues of diagnostic
information. Given the growth of research into host–
microbiome interactions, insight into the net microbial
activity in the oral cavity afforded by salivary metabolic
profiling represents an additional advantage of saliva as
a diagnostic fluid. This is particularly true considering
multiple oral diseases are of bacterial aetiology [9,11].
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